Iran Hawks Pressuring White House To Halt 'Humanitarian' Medicine To Iran Amid Outbreak [zero hedge]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: zero hedge
Iran Hawks Pressuring White House To Halt 'Humanitarian' Medicine To Iran Amid Outbreak An influential US lobbying group tied to Republican hawks is attempting convince the Trump administration to block all medicine sales to Iran after the US Treasury recently opened up humanitarian channels due to Iran's devastating coronavirus outbreak. Despite the daily soaring infection rate and death toll, with Iran on Friday confirming 124 deaths amid 4747 confirmed cases — though true numbers are believed much higher — the hawkish pressure group, United Against Nuclear Iran , wants to ensure all medical trade dries up . Last month the US administration came under fire based on the allegation that aggressive and tightening US-led sanctions of the past two years have actually exacerbated the new Covid-19 crisis in Iran , not only setting the conditions for rapid spread but weakening the medical response for lack of equipment, medicines, and ability to test. Coronavirus testing in Iran, file
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- U.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer [Yahoo! Finance]Yahoo! Finance
- U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal CancerBusiness Wire
- Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now? [Yahoo! Finance]Yahoo! Finance
- Why Pfizer (PFE) Dipped More Than Broader Market Today [Yahoo! Finance]Yahoo! Finance
- GoComet's Odyssey Singapore 2024 Highlights: When Supply Chain Giants MeetPR Web
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/17/24 - Form 8-K
- PFE's page on the SEC website